429 related articles for article (PubMed ID: 27550791)
1. Proteomic profiling of human plasma for cancer biomarker discovery.
Huang Z; Ma L; Huang C; Li Q; Nice EC
Proteomics; 2017 Mar; 17(6):. PubMed ID: 27550791
[TBL] [Abstract][Full Text] [Related]
2. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
Smith JG; Gerszten RE
Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
[TBL] [Abstract][Full Text] [Related]
3. Optomechanical devices for deep plasma cancer proteomics.
Kosaka PM; Calleja M; Tamayo J
Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
[TBL] [Abstract][Full Text] [Related]
4. Tissue and plasma proteomics for early stage cancer detection.
Peng L; Cantor DI; Huang C; Wang K; Baker MS; Nice EC
Mol Omics; 2018 Dec; 14(6):405-423. PubMed ID: 30251724
[TBL] [Abstract][Full Text] [Related]
5. Plasma proteomics, the Human Proteome Project, and cancer-associated alternative splice variant proteins.
Omenn GS
Biochim Biophys Acta; 2014 May; 1844(5):866-73. PubMed ID: 24211518
[TBL] [Abstract][Full Text] [Related]
6. Oncoproteomics: Trials and tribulations.
Zhou L; Li Q; Wang J; Huang C; Nice EC
Proteomics Clin Appl; 2016 Apr; 10(4):516-31. PubMed ID: 26518147
[TBL] [Abstract][Full Text] [Related]
7. The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer.
Zhang H; Fan Y; Xia L; Gao C; Tong X; Wang H; Sun L; Ji T; Jin M; Gu B; Fan B
Tumour Biol; 2017 Mar; 39(3):1010428317691183. PubMed ID: 28345451
[TBL] [Abstract][Full Text] [Related]
8. Mining the plasma proteome for cancer biomarkers.
Hanash SM; Pitteri SJ; Faca VM
Nature; 2008 Apr; 452(7187):571-9. PubMed ID: 18385731
[TBL] [Abstract][Full Text] [Related]
9. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
[TBL] [Abstract][Full Text] [Related]
10. Strategies for plasma proteomic profiling of cancers.
Omenn GS
Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
[TBL] [Abstract][Full Text] [Related]
11. The blood peptidome: a higher dimension of information content for cancer biomarker discovery.
Petricoin EF; Belluco C; Araujo RP; Liotta LA
Nat Rev Cancer; 2006 Dec; 6(12):961-7. PubMed ID: 17093504
[TBL] [Abstract][Full Text] [Related]
12. Mass Spectrometry-Based Analysis for the Discovery and Validation of Potential Colorectal Cancer Stool Biomarkers.
Ang CS; Baker MS; Nice EC
Methods Enzymol; 2017; 586():247-274. PubMed ID: 28137566
[TBL] [Abstract][Full Text] [Related]
13. Inconvenient truth: cancer biomarker development by using proteomics.
Kondo T
Biochim Biophys Acta; 2014 May; 1844(5):861-5. PubMed ID: 23896458
[TBL] [Abstract][Full Text] [Related]
14. Innovative proteomic approaches for cancer biomarker discovery.
Faca V; Krasnoselsky A; Hanash S
Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
[TBL] [Abstract][Full Text] [Related]
15. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
Shukla HD; Mahmood J; Vujaskovic Z
Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling of pancreatic cancer for biomarker discovery.
Chen R; Pan S; Brentnall TA; Aebersold R
Mol Cell Proteomics; 2005 Apr; 4(4):523-33. PubMed ID: 15684406
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry.
Cominetti O; Núñez Galindo A; Corthésy J; Oller Moreno S; Irincheeva I; Valsesia A; Astrup A; Saris WH; Hager J; Kussmann M; Dayon L
J Proteome Res; 2016 Feb; 15(2):389-99. PubMed ID: 26620284
[TBL] [Abstract][Full Text] [Related]
18. Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics.
Mehan MR; Ostroff R; Wilcox SK; Steele F; Schneider D; Jarvis TC; Baird GS; Gold L; Janjic N
Adv Exp Med Biol; 2013; 735():283-300. PubMed ID: 23402035
[TBL] [Abstract][Full Text] [Related]
19. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
Lee PY; Chin SF; Low TY; Jamal R
J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
[TBL] [Abstract][Full Text] [Related]
20. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
Wang K; Huang C; Nice EC
Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]